首页> 美国卫生研究院文献>Experimental and Therapeutic Medicine >Correlation of abdominal fat ratio with hepatic CT enhancement
【2h】

Correlation of abdominal fat ratio with hepatic CT enhancement

机译:腹部脂肪比例与肝脏CT增强的相关性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The objective of the study was to evaluate the effect of abdominal fat proportion on hepatic computed tomography (CT) enhancement. CT data for 87 patients (47 men, mean age 55.09±13.27 years; 40 women, mean age 60.43±11.29 years) were analyzed by linear regression to assess the association of patient age and abdominal fat proportion with adjusted maximal hepatic enhancement (aMHE), calculated by dividing the maximal hepatic enhancement by the dose of iodine injected per kilogram of patient body weight, for each gender. The abdominal fat ratio (AFR) at the umbilical level, calculated as the volume of abdominal fat divided by the total abdominal volume, was used as a marker of abdominal fat proportion. It was found that aMHE was positively correlated with AFR for men (r=0.48, P<0.01) and women (r=0.46, P<0.01) but not with patient age (r=-0.09 and −0.14, respectively, both P>0.05). Therefore, it was concluded that determining an iodine dose on the basis of AFR might be an optimal way to maintain constant hepatic enhancement.
机译:这项研究的目的是评估腹部脂肪比例对肝脏计算机断层扫描(CT)增强的影响。通过线性回归分析分析了87例患者的CT数据(47例男性,平均年龄55.09±13.27岁; 40例女性,平均年龄60.43±11.29岁),以评估患者年龄和腹部脂肪比例与最大肝功能增强(aMHE)的相关性,计算方法是将每种性别的最大肝脏增强量除以每公斤患者体重所注射的碘剂量。脐带水平的腹部脂肪比率(AFR),用腹部脂肪的体积除以腹部总体积计算,用作腹部脂肪比例的标志。研究发现,男性(r = 0.48,P <0.01)和女性(r = 0.46,P <0.01)的aMHE与AFR呈正相关,但与患者年龄(r = -0.09和-0.14)均不相关> 0.05)。因此,可以得出结论,基于AFR确定碘剂量可能是维持恒定肝功能增强的最佳方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号